State Street Corp Ginkgo Bioworks Holdings, Inc. Transaction History

State Street Corp

  • $2.41 Trillion
  • Q3 2024

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024
SELL
$0.28 - $1.16 $4.62 Million - $19.1 Million
-16,492,829 Reduced 62.04%
10,092,665 $3.33 Million
Q1 2024

May 15, 2024
BUY
$1.06 - $1.67 $563,758 - $888,186
531,848 Added 2.04%
26,585,494 $30.8 Million
Q4 2023

Feb 14, 2024
BUY
$1.26 - $1.79 $4.54 Million - $6.44 Million
3,599,910 Added 16.03%
26,053,646 $44 Million
Q3 2023

Nov 14, 2023
BUY
$1.61 - $2.54 $2.85 Million - $4.5 Million
1,769,984 Added 8.56%
22,453,736 $40.6 Million
Q2 2023

Aug 14, 2023
BUY
$1.14 - $1.95 $6.81 Million - $11.7 Million
5,976,244 Added 40.63%
20,683,752 $38.5 Million
Q1 2023

May 15, 2023
BUY
$1.2 - $2.19 $961,178 - $1.75 Million
800,982 Added 5.76%
14,707,508 $19.6 Million
Q4 2022

Feb 14, 2023
BUY
$1.63 - $3.52 $1.17 Million - $2.52 Million
715,840 Added 5.43%
13,906,526 $23.5 Million
Q3 2022

Nov 15, 2022
BUY
$0.73 - $3.74 $568,546 - $2.91 Million
778,831 Added 6.27%
13,190,686 $41.2 Million
Q2 2022

Aug 15, 2022
BUY
$2.2 - $4.2 $18.5 Million - $35.3 Million
8,411,787 Added 210.29%
12,411,855 $29.5 Million
Q1 2022

May 16, 2022
BUY
$2.83 - $8.69 $572,800 - $1.76 Million
202,403 Added 5.33%
4,000,068 $16.1 Million
Q4 2021

Feb 14, 2022
BUY
$8.31 - $14.92 $31.6 Million - $56.7 Million
3,797,665 New
3,797,665 $31.6 Million

Others Institutions Holding DNA

# of Institutions
40
Shares Held
48.1M
Call Options Held
0
Put Options Held
0
View Full List

About Ginkgo Bioworks Holdings, Inc.

DNA Quotes by TradingView
  • Ticker DNA
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 1,287,779,968
  • Market Cap $12.1B
  • Description
  • Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agric...
More about DNA
Track This Portfolio

Track State Street Corp Portfolio

Follow State Street Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email